The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the ratio of plasma fibrinogen to platelet in resectable pancreatic cancer.
 
Yusuke Arakawa
No Relationships to Disclose
 
Mitsuo Shimada
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Bayer Yakuhin (Inst); Bayer Yakuhin (Inst); Bayer Yakuhin (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Covidien (Inst); Covidien (Inst); Covidien (Inst); Covidien (Inst); CSL Behring (Inst); CSL Behring (Inst); CSL Behring (Inst); CSL Behring (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); TSUMURA & CO. (Inst); TSUMURA & CO. (Inst); TSUMURA & CO. (Inst); TSUMURA & CO. (Inst)
 
Yuji Morine
No Relationships to Disclose
 
Satoru Imura
No Relationships to Disclose
 
Tetsuya Ikemoto
No Relationships to Disclose
 
Yu Saito
No Relationships to Disclose
 
Shinichiro Yamada
No Relationships to Disclose
 
Masato Yoshikawa
No Relationships to Disclose
 
Katsuki Miyazaki
No Relationships to Disclose